Thursday, November 12, 2026

EUR/GBP Bearish By 1% In The Last 21 Sessions

EUR/GBP Bearish By 1% In The Last 21 Sessions

(VIANEWS) - EUR/GBP (EURGBP) has been up by 1.55% for the last 21 sessions. At 13:09 EST on Friday, 19 May, EUR/GBP (EURGBP) is $0.87.

EUR/GBP's yearly highs and lows, it's 4.065% up from its 52-week low and 6.031% down from its 52-week high.

Volatility

EUR/GBP's last week, last month's, and last quarter's current intraday variation average was a negative 0.10%, a negative 0.14%, and a positive 0.27%, respectively.

EUR/GBP's highest amplitude of average volatility was 0.20% (last week), 0.26% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/GBP's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy prods five-day uptrend above 136.00 on upbeat Japan gdp, receding US default fears. According to FXStreet on Wednesday, 17 May, "Unless dropping back below the early-month top surrounding 135.50, the USD/JPY remains capable of marking another attempt in crossing the 200-DMA hurdle of around 137.10.", "Apart from the Japanese GDP, recent hopes of more investment by private firms in Japan also weigh on the USD/JPY pair. "
  • Usd/jpy trades with modest losses around mid-137.00s, downside seems cushioned. According to FXStreet on Thursday, 18 May, "Traders will further take cues from speeches by influential FOMC members, which, along with the US bond yields, will drive the USD demand and provide some impetus to the USD/JPY pair. ", "That said, a combination of factors continues to act as a tailwind for the USD/JPY pair and limit the downside, warranting some caution for aggressive bearish traders."
  • Usd/jpy price analysis: climbs above 136.50 despite upbeat Japan’s GDP. According to FXStreet on Wednesday, 17 May, "The USD/JPY pair has resumed its upside journey after a marginal correction below 136.50 in the Asian session. ", "This would drag the USD/JPY pair towards May 11 high at 134.84 followed by May 11 low at 133.74."
  • Usd/jpy looks to build on bullish move beyond 137.00, 200 DMA on stronger USD. According to FXStreet on Wednesday, 17 May, "Nevertheless, the aforementioned fundamental backdrop suggests that the path of least resistance for the USD/JPY pair is to the upside. ", "The US Dollar (USD) continues to draw support from the recent hawkish remarks by several Federal Reserve (Fed) officials and climbs to a nearly two-month high, which, in turn, is seen as a key factor acting as a tailwind for the USD/JPY pair. "

More news about EUR/GBP (EURGBP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com